Taking the Next Step in RBQM Strategy: Smarter Monitoring for Stronger Trials

April 16th, 2026
11 a.m. EST

Risk-based quality management (RBQM) has become a cornerstone of modern clinical trial execution, helping sponsors proactively manage risk to improve data integrity, patient safety, and operational efficiency. Industry adoption continues to improve; data from the Association of Clinical Research Organizations (ACRO) shows that in 2024, 96% of trials incorporated at least one RBM or RBQM component. However, taking the next step requires implementation of a holistic RBQM strategy that relies on fully integrated, cross-functional approaches – and this remains variable across the industry. 

This webinar will explore how sponsors can build sustainable RBQM frameworks that move beyond compliance toward measurable, long-term value. Attendees will learn the core elements of successful RBQM strategies, the expanding role and impact of central monitoring, and real-world results from a central monitoring assessment case study. The session will also address common implementation challenges and practical approaches for strengthening RBQM through processes tailored to specific study needs. 

Register to learn how a mature and intentional RBQM strategy can drive higher quality, more efficient clinical development programs. 

Attendees will gain insights into: 

• Metrics that support the need for greater adoption of RBQM
• Elements of a successful RBQM strategy 
• The value of central monitoring and its evolving role in clinical research 

Registration Coming Soon  

Speakers:

Dmitri Berman – Vice President, Global Clinical Operations

Sources:

1. Association of Clinical Research Organizations (ACRO). RBQM Landscape Summary Report. June 2025. https://www.acrohealth.org/wp-content/uploads/2025/06/ACRO_2025-RBQM-Report_Final-062425.pdf